NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 7003-7009

  Poynter, Matthew E ^a,b   Cloots, Roy ^b   Van Woerkom, Tiest ^a   Butnor, Kelly J ^b   Vacek, Pamela ^a,b   Taatjes, Douglas J ^b   Irvin, Charles G ^a   Janssen Heininger, Yvonne M W ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; IMMUNE RESPONSE; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 9144241104     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.7003     Document Type: Article

References (51)

1. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853.
2. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
3. Das, J., C. H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray. 2001. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45.
4. Donovan, C. E., D. A. Mark, H. Z. He, H. C. Liou, L. Kobzik, Y. Wang, G. T. De Sanctis, D. L. Perkins, and P. W. Finn. 1999. NF-κB/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol. 163:6827.
5. Yang, B. L., L. Cohn, D.-H. Zhang, R. Homer, A. Ray, and P. Ray. 1998. Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188:1739.
6. Poynter, M., C. Irvin, and Y. Janssen-Heniniger. 2002. Rapid activation of nuclear factor-κB in airway epithelium in a murine model of allergic airway inflammation. Am. J. Pathol. 160:1325.
7. Bureau, F., G. Bonizzi, N. Kirschvink, S. Delhalle, D. Desmecht, M. P. Merville, V. Bours, and P. Lekeux. 2000. Correlation between nuclear factor-κB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am. J. Respir. Crit. Care Med. 161:1314.
8. Hamilton, L. M., D. E. Davies, S. J. Wilson, I. Kimber, R. J. Dearman, and S. T. Holgate. 2001. The bronchial epithelium in asthma - Much more than a passive barrier. Monaldi. Arch. Chest Dis. 56:48.
9. Zhao, S., Y. Qi, X. Liu, Q. Jiang, S. Liu, Y. Jiang, and Z. Jiang. 2001. Activation of NF-κB in bronchial epithelial cells from children with asthma. Chin. Med. J. 114:909.
10. Stacey, M. A., G. Sun, G. Vassalli, M. Marini, A. Bellini, and S. Mattoli. 1997. The allergen Der p1 induces NF-κB activation through interference with IκBα function in asthmatic bronchial epithelial cells. Biochem. Biophys. Res. Commun. 236:522.
11. Vignola, A. M., G. Chiappara, L. Siena, A. Bruno, R. Gagliardo, A. M. Merendino, B. S. Polla, A. P. Arrigo, G. Bonsignore, J. Bousquet, and P. Chanez. 2001. Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma. J. Allergy Clin. Immunol. 108:738.
12. Hart, L., S. Lim, I. Adcock, P. J. Barnes, and K. F. Chung. 2000. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB in asthma. Am. J. Respir. Crit. Care Med. 161:224.
13. Hart, L. A., V. L. Krishnan, I. M. Adcock, P. J. Barnes, and K. F. Chung. 1998. Activation and localization of transcription factor, nuclear factor-κB, in asthma. Am. J. Respir. Crit. Care Med. 158:1585.
14. Poynter, M., C. Irvin, and Y. Janssen-Heininger. 2003. A prominent role for airway epithelial NF-κB activation in lipopolysaccharide-induced airway inflammation. J. Immunol. 170:6257.
15. Tomioka, S., J. H. Bates, and C. G. Irvin. 2002. Airway and tissue mechanics in a murine model of asthma: Alveolar capsule vs. forced oscillations. J. Appl. Physiol. 93:263.
16. Hantos, Z., B. Daroczy, B. Suki, S. Nagy, and J. J. Fredberg. 1992. Input impedance and peripheral inhomogeneity of dog lungs. J. Appl. Physiol. 72:168.
17. Lampinen, M., M. Carlson, L. D. Hakansson, and P. Venge. 2004. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59:793.
18. Chensue, S. W., N. W. Lukacs, T. Y. Yang, X. Shang, K. A. Frait, S. L. Kunkel, T. Kung, M. T. Wiekowski, J. A. Hedrick, D. N. Cook, A. Zingoni, S. K. Narula, A. Zlotnik, F. J. Barrat, A. O'Garra, M. Napolitano, and S. A. Lira. 2001. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 193:573.
19. Rose, C. E., Jr., S. S. Sung, and S. M. Fu. 2003. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10:273.
20. Medoff, B. D., A. Sauty, A. M. Tager, J. A. Maclean, R. N. Smith, A. Mathew, J. H. Dufour, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J. Immunol. 168:5278.
21. Fujiie, S., K. Hieshima, D. Izawa, T. Nakayama, R. Fujisawa, H. Ohyanagi, and O. Yoshie. 2001. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3α/CCL20 in mucosal epithelial cells through NF-κB [correction of NK-κB]. Int. Immunol. 13:1255.
22. Starner, T. D., C. K. Barker, H. P. Jia, Y. Kang, and P. B. McCray, Jr. 2003. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am. J. Respir. Cell Mol. Biol. 29:627.
23. Campbell, J. J., J. Hedrick, A. Zlotnik, M. A. Siani, D. A. Thompson, and E. C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279:381.
24. Nakanishi, A., S. Morita, H. Iwashita, Y. Sagiya, Y. Ashida, H. Shirafuji, Y. Fujisawa, O. Nishimura, and M. Fujino. 2001. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc. Natl. Acad. Sci. USA 98:5175.
25. Zuhdi Alimam, M., F. M. Piazza, D. M. Selby, N. Letwin, L. Huang, and M. C. Rose. 2000. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am. J. Respir. Cell Mol. Biol. 22:253.
26. Burrows, B., M. R. Sears, E. M. Flannery, G. P. Herbison, and M. D. Holdaway. 1992. Relationships of bronchial responsiveness assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children. J. Allergy Clin. Immunol. 90:376.
27. Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161:1720.
28. Barnes, P. J. 1999. Therapeutic strategies for allergic diseases. Nature 402:B31.
29. Lee, J. I., and G. J. Burckart. 1998. Nuclear factor κB: Important transcription factor and therapeutic target. J. Clin. Pharmacol. 38:981.
30. Kang, J. L., H. W. Lee, H. S. Lee, I. S. Pack, Y. Chong, V. Castranova, and Y. Koh. 2001. Genistein prevents nuclear factor-κB activation and acute lung injury induced by lipopolysaccharide. Am. J. Respir. Crit. Care Med. 164:2206.
31. Held, H. D., S. Boettcher, L. Hamann, and S. Uhlig. 2001. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-κB and is blocked by steroids. Am. J. Respir. Crit. Care Med. 163:711.
32. Blackwell, T. S., L. H. Lancaster, T. R. Blackwell, A. Venkatakrishnan, and J. W. Christman. 1999. Differential NF-κB activation after intratracheal endotoxin. Am. J. Physiol. 277:L823.
33. Walley, K. R., T. E. McDonald, Y. Higashimoto, and S. Hayashi. 1999. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am. J. Respir. Crit. Care Med. 160:698.
34. Bureau, F., S. Delhalle, G. Bonizzi, L. Fievez, S. Dogne, N. Kirschvink, A. Vanderplasschen, M. P. Merville, V. Bours, and P. Lekeux. 2000. Mechanisms of persistent NF-κB activity in the bronchi of an animal model of asthma. J. Immunol. 165:5822.
35. Suda, T., A. Sato, W. Sugiura, and K. Chida. 1995. Induction of MHC class II antigens on rat bronchial epithelial cells by interferon-α and its effect on antigen presentation. Lung 173:127.
36. Kurosawa, S., A. C. Myers, L. Chen, S. Wang, J. Ni, J. R. Plitt, N. M. Heller, B. S. Bochner, and R. P. Schleimer. 2003. Expression of the costimulatory molecule B7-H2 (inducible costimulator ligand) by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 28:563.
37. Schwiebert, L. M., R. P. Schleimer, S. F. Radka, and S. J. Ono. 1995. Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol. 165:12.
38. Atsuta, J., S. A. Sterbinsky, J. Plitt, L. M. Schwiebert, B. S. Bochner, and R. P. Schleimer. 1997. Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: Demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. Am. J. Respir. Cell Mol. Biol. 17:571.
39. Takeda, K., E. Hamelmann, A. Joetham, L. D. Shultz, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997, Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186:449.
40. Whittaker, L., N. Niu, U. A. Temann, A. Stoddard, R. A. Flavell, A. Ray, R. J. Homer, and L. Cohn. 2002. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am. J. Respir. Cell Mol. Biol. 27:593.
41. Crimi, E., A. Spanevello, M. Neri, P. W. Ind, G. A. Rossi, and V. Brusasco. 1998. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157:4.
42. Brewer, J. P., A. B. Kisselgof, and T. R. Martin. 1999. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am. J. Respir. Crit. Care Med. 160:1150.
43. Ewart, S. L., D. Kuperman, E. Schadt, C. Tankersley, A. Grupe, D. M. Shubitowski, G. Peltz, and M. Wills-Karp. 2000. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am. J. Respir. Cell Mol. Biol. 23:537.
44. Wagers, S. S., R. J. Norton, L. M. Rinaldi, J. H. Bates, B. E. Sobel, and C. G. Irvin. 2004. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J. Clin. Invest. 114:104.
45. Kraft, M., R. Djukanovic, S. Wilson, S. T. Holgate, and R. J. Martin. 1996. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 154:1505.
46. Epstein, M. M. 2004. Do mouse models of allergic asthma mimic clinical disease? Int. Arch. Allergy Immunol. 133:84.
47. Kips, J. C., G. P. Anderson, J. J. Fredberg, U. Herz, M. D. Inman, M. Jordana, D. M. Kemeny, J. Lotvall, R. A. Pauwels, C. G. Plopper, D. Schmidt, P. J. Sterk, A. J. Van Oosterhout, B. B. Vargaftig, and K. F. Chung. 2003. Murine models of asthma. Eur. Respir. J. 22:374.
48. Kumar, R. K., and P. S. Foster. 2002. Modeling allergic asthma in mice: Pitfalls and opportunities. Am. J. Respir. Cell Mol. Biol. 27:267.
49. Kaminsky, D. A., J. H. Bates, and C. G. Irvin. 2000. Effects of cool, dry air stimulation on peripheral lung mechanics in asthma. Am. J. Respir. Crit. Care Med. 162:179.
50. Wagers, S. S., T. G. Bouder, D. A. Kaminsky, and C. G. Irvin. 2000. The invaluable pressure-volume curve. Chest 117:578.
51. Kaminsky, D. A., S. E. Wenzel, C. Carcano, D. Gurka, D. Feldsien, and C. G. Irvin. 1997. Hyperpnea-induced changes in parenchymal lung mechanics in normal subjects and in asthmatics. Am. J. Respir. Crit. Care Med. 155:1260.